CIK: 0001502287 · Show all filings
Period: Q1 2016 (← Previous) (Next →)
Filing Date: May 13, 2016
Total Value ($000): $71,879 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NVCR | NOVOCURE LTD | 1,815,479 | $26,288 | 36.6% | $14.35 | 0.0% | ORD SHS | G6674U108 |
| — | TRANSENTERIX INC | 3,480,512 | $14,792 | 20.6% | $5.04 | — | COM NEW | 89366M201 |
| — | CAESARS ENTMT CORP | 1,665,032 | $11,322 | 15.8% | $17.62 | — | COM | 127686103 |
| — | CAESARS ACQUISITION CO | 1,665,032 | $10,190 | 14.2% | $14.21 | — | CL A | 12768T103 |
| FDUS | FIDUS INVT CORP | 260,105 | $4,034 | 5.6% | $4.67 | -1.2% | COM | 316500107 |
| VEEV | VEEVA SYS INC | 160,000 | $4,006 | 5.6% | $24.49 | 0.0% | CL A COM | 922475108 |
| QNST | QUINSTREET INC | 270,114 | $924 | 1.3% | $8.86 | -61.7% | COM | 74874Q100 |
| — | ALPHATEC HOLDINGS INC | 1,344,179 | $323 | 0.4% | $1.97 | — | COM | 02081G102 |